Related Experiment Video

Updated: May 6, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

981

Glutaminase regulation in cancer cells: a druggable chain of events

William P Katt1, Richard A Cerione1

  • 1Department of Molecular Medicine, Cornell University, Ithaca, NY 14853-6401, USA.

Drug Discovery Today
|October 22, 2013
PubMed

Insights

Cancer cells exhibit altered metabolism, leading to glutamine dependency. This review explores glutaminase regulation and therapeutic strategies targeting this key enzyme in cancer treatment.

Area of Science:

  • Oncology
  • Cellular Metabolism
  • Biochemistry

Background:

  • Cancer cells exhibit altered metabolic pathways, notably the Warburg effect.
  • This metabolic reprogramming results in a dependency on glutamine for cancer cell growth and survival.
  • The enzyme glutaminase is a critical mediator of glutamine metabolism and a significant therapeutic target in oncology.

Purpose of the Study:

  • To review recent advancements in understanding glutaminase regulation in cancer.
  • To identify upstream regulatory partners of glutaminase as potential therapeutic targets.
  • To propose therapeutic intervention strategies targeting glutaminase and its network.

Main Methods:

  • Literature review of studies published in the current decade.
  • Analysis of research on glutaminase function and regulation.
  • Exploration of upstream signaling pathways influencing glutaminase activity.

Main Results:

  • Glutamine addiction is a hallmark of cancer cells due to metabolic alterations.
  • Glutaminase plays a central role in glutamine metabolism, making it a key target for anti-cancer drugs.
  • Upstream regulators of glutaminase present additional opportunities for therapeutic development.

Conclusions:

  • Targeting glutaminase offers a promising strategy for cancer therapy.
  • Understanding glutaminase regulation and its upstream partners is crucial for developing effective interventions.
  • Combined therapeutic approaches targeting glutaminase and its network may enhance treatment efficacy.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

19.0K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K